San Diego, CA · Founded 2022 · Privately Held (backing)
Operator of a clinical-stage oncology platform intended to develop novel treatments for underserved cancers. Avenzo Therapeutics is based in San Diego, CA and was founded in 2022. It was valued at $590 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $446 million across 2 recorded rounds; the latest was a $47.2 million early-stage round in Aug 2025.
PMV mark · valuation
$590.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$445.9M
Last round
Early Stage VC
Aug 2025
Cap table — not yet on record
Avenzo Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Avenzo Therapeutics with a free account
·The complete investor list: 15 names
·Watch Avenzo Therapeutics: the Monday email on marks, rounds and moves
Where does Avenzo Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Avenzo Therapeutics's 2 recorded funding rounds.
